Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

Health Canada has approved Novo Nordisk’s semaglutide injection, Wegovy, to reduce the risk of non-fatal myocardial ...

The success of GLP-1R-targeting drugs highlights their viability as a treatment approach. Currently, there are four ...

Additional 7.5 million Americans covered under Biden's plan The Biden Administration has announced that it wants to expand <a ...

Health Canada has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial ...

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.

The U.S. Food and Drug Administration is weighing the need for a regulatory action on bluebird bio's gene therapy for a rare ...

A drug used to help Canadians lose weight has now been approved to reduce the risk of non-fatal heart attacks. Novo Nordisk ...

Key Takeaways A new Amgen weight reduction drug, MariTide, has bred successful results after a 52-week study. Still, AMGN ...